REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 75 filers reported holding REVANCE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.17 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,610,781 | -52.0% | 663,538 | +5.8% | 0.00% | -60.0% |
| Q2 2023 | $15,870,509 | -18.9% | 627,045 | +3.2% | 0.01% | -16.7% |
| Q1 2023 | $19,562,260 | +74.7% | 607,335 | +0.1% | 0.01% | +50.0% |
| Q4 2022 | $11,198,168 | -27.1% | 606,618 | +6.7% | 0.00% | -20.0% |
| Q3 2022 | $15,352,000 | +130.6% | 568,559 | +18.0% | 0.01% | +150.0% |
| Q2 2022 | $6,658,000 | -30.5% | 481,715 | -2.0% | 0.00% | -33.3% |
| Q1 2022 | $9,584,000 | +23.2% | 491,462 | +3.1% | 0.00% | +50.0% |
| Q4 2021 | $7,782,000 | -40.7% | 476,824 | +1.2% | 0.00% | -50.0% |
| Q3 2021 | $13,130,000 | -5.4% | 471,267 | +0.7% | 0.00% | -20.0% |
| Q2 2021 | $13,878,000 | +11.1% | 468,211 | +4.8% | 0.01% | 0.0% |
| Q1 2021 | $12,493,000 | +7.2% | 446,941 | +8.7% | 0.01% | 0.0% |
| Q4 2020 | $11,649,000 | +14.2% | 411,031 | +1.3% | 0.01% | 0.0% |
| Q3 2020 | $10,204,000 | +24.3% | 405,862 | +20.8% | 0.01% | +25.0% |
| Q2 2020 | $8,206,000 | +81.7% | 336,020 | +10.1% | 0.00% | +33.3% |
| Q1 2020 | $4,517,000 | +3.3% | 305,174 | +13.3% | 0.00% | +50.0% |
| Q4 2019 | $4,372,000 | +37.2% | 269,359 | +9.9% | 0.00% | 0.0% |
| Q3 2019 | $3,187,000 | +1.2% | 245,085 | +1.0% | 0.00% | 0.0% |
| Q2 2019 | $3,149,000 | -11.4% | 242,764 | +7.7% | 0.00% | 0.0% |
| Q1 2019 | $3,553,000 | -0.3% | 225,381 | +27.3% | 0.00% | -33.3% |
| Q4 2018 | $3,564,000 | -19.4% | 177,028 | -0.5% | 0.00% | 0.0% |
| Q3 2018 | $4,422,000 | +5.4% | 177,926 | +16.4% | 0.00% | 0.0% |
| Q2 2018 | $4,195,000 | +1.2% | 152,795 | +13.5% | 0.00% | 0.0% |
| Q1 2018 | $4,147,000 | -2.0% | 134,616 | +13.8% | 0.00% | 0.0% |
| Q4 2017 | $4,230,000 | +30.9% | 118,309 | +0.9% | 0.00% | 0.0% |
| Q3 2017 | $3,231,000 | +9.5% | 117,258 | +4.9% | 0.00% | 0.0% |
| Q2 2017 | $2,951,000 | +53.4% | 111,757 | +20.8% | 0.00% | +50.0% |
| Q1 2017 | $1,924,000 | +4.9% | 92,490 | +4.4% | 0.00% | 0.0% |
| Q4 2016 | $1,834,000 | +89.5% | 88,557 | +48.3% | 0.00% | +100.0% |
| Q3 2016 | $968,000 | +7.3% | 59,715 | -9.9% | 0.00% | 0.0% |
| Q2 2016 | $902,000 | -20.5% | 66,263 | +2.0% | 0.00% | 0.0% |
| Q1 2016 | $1,134,000 | -47.7% | 64,943 | +2.3% | 0.00% | -66.7% |
| Q4 2015 | $2,169,000 | +55.5% | 63,467 | +35.5% | 0.00% | +50.0% |
| Q3 2015 | $1,395,000 | +20.4% | 46,842 | +29.3% | 0.00% | 0.0% |
| Q2 2015 | $1,159,000 | +109.6% | 36,234 | +35.8% | 0.00% | +100.0% |
| Q1 2015 | $553,000 | +29.5% | 26,673 | +6.0% | 0.00% | 0.0% |
| Q4 2014 | $427,000 | +14.5% | 25,165 | +30.7% | 0.00% | 0.0% |
| Q3 2014 | $373,000 | -29.0% | 19,247 | +24.8% | 0.00% | 0.0% |
| Q2 2014 | $525,000 | – | 15,428 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |